Lecture/Seminar

STAR Spotlight Series: Evidence for Complimentary and Integrative Treatments for ASD

Monday, July 22 at 6:00 pm - 7:00 pm Add to Calendar 2019-07-23 01:00:00 2019-07-23 02:00:00 STAR Spotlight Series: Evidence for Complimentary and Integrative Treatments for ASD Please join us for our next community talk featuring STAR co-director Robert Hendren, DO. Dr. Hendren completeed his residency in general psychiatry at the Mayo Graduate School of Medicine, and his child and adolescent psychiatry fellowship at the Yale Child Study Center. He is board certified in General as well as Child and Adolescent Psychiatry. From 2001-2009, he was Professor of Psychiatry and Executive Director and Tsakopoulos-Vismara Chair at the University of California, Davis M.I.N.D. Institute (Medical Investigation of Neurodevelopmental Disorders). His current areas of research and publication interests are translational interventional research including clinical pharmacology, nutraceutical and nutritional trials using biomarkers (MRI, measures of inflammation, oxidative stress, immune function and pharmacogenomics) to enhance resilience in neurodevelopmental disorders. He is currently applying this targeted outcomes research focus in a collaborative project with the Oak Hill School for youth with severe autism and neurodevelopmental spectrum disorders in San Anselmo, CA. Dr. Hendren is also past president of the American Academy of Child and Adolescent Psychiatry (2007-2009). He has published over 100 scientific papers and 5 books and has been listed in “The Best Doctors in America”, each year since it was first published in 1996. 401 Parnassus Avenue LP-190 Auditorium San Francisco, CA 94143 United States View on Map Department Of Psychiatry UCSF Weill Institute For Neurosciences idil.yazgan@ucsf.edu America/Los_Angeles public

401 Parnassus Avenue
LP-190 Auditorium
San Francisco, CA 94143
United States

View on Map

Please join us for our next community talk featuring STAR co-director Robert Hendren, DO.

Dr. Hendren completeed his residency in general psychiatry at the Mayo Graduate School of Medicine, and his child and adolescent psychiatry fellowship at the Yale Child Study Center. He is board certified in General as well as Child and Adolescent Psychiatry. From 2001-2009, he was Professor of Psychiatry and Executive Director and Tsakopoulos-Vismara Chair at the University of California, Davis M.I.N.D. Institute (Medical Investigation of Neurodevelopmental Disorders).

His current areas of research and publication interests are translational interventional research including clinical pharmacology, nutraceutical and nutritional trials using biomarkers (MRI, measures of inflammation, oxidative stress, immune function and pharmacogenomics) to enhance resilience in neurodevelopmental disorders. He is currently applying this targeted outcomes research focus in a collaborative project with the Oak Hill School for youth with severe autism and neurodevelopmental spectrum disorders in San Anselmo, CA.

Dr. Hendren is also past president of the American Academy of Child and Adolescent Psychiatry (2007-2009). He has published over 100 scientific papers and 5 books and has been listed in “The Best Doctors in America”, each year since it was first published in 1996.

Pulseofucsf